Selected price target: $38 per share, roughly 87% above the August 12, 2026 close near $20.35. Bullish factors: an 11.5-gigawatt development pipeline, blue-chip partners, proprietary TRISO-X fuel technology, and a Buy-leaning analyst consensus with a $37.86 average target.

SailPoint, Inc. ( SAIL ) closed at $18.73 on August 12, 2026, meaning a move to $25 would require roughly 33% upside. The $25 stock price target is the most bullish published 12-month analyst objective and sits just above the stock's 52-week high of $24.00.

Maase Inc. ( MAAS ) is a NASDAQ-listed common stock, not an exchange-traded fund (ETF); it closed at $16.42 in the latest regular session, with after-hours trading near $16.58. The selected $30 stock price target sits roughly 83% above the latest close and would require a decisive breakout beyond the 52-week high of $24.90.

Selected target: $20 per share, roughly 44% above Avantor's recent price near $13.93 and above the highest current Street target of $19. Strongest bullish factors: a second-quarter earnings beat, raised fiscal 2026 adjusted EPS guidance, cost-savings turnaround efforts, a $500 million buyback authorization, and expansion in high-purity silicone applications.

The selected stock price target is $24 , about 34% above BMNR's recent close near $17.89. $24 sits just below the lowest current Wall Street 12-month analyst target of $25 and near a widely discussed $23–$24 resistance zone.

Blue Owl Capital shares rose approximately 31.5% in the 30 days through August 12, 2026, climbing from a July 13 close of $9.29 to a latest available price of $12.22. Second-quarter 2026 results, released July 30, showed distributable earnings per share of $0.22 in line with consensus and fee-related revenue above estimates, fueling a 6.4% single-session gain.

EQX shares rose roughly 22% over the 30-day stretch from mid-July to mid-August 2026, moving from a July 13, 2026 close of $9.45 to about $11.55 in the latest available session. The advance coincided with a sharp rebound in gold, which posted its largest one-day gain since February on August 5, 2026, and extended above $4,300 per ounce.

CHYM rose about 50.8% over the past 30 days, from a closing price of $20.95 on July 13, 2026, to $31.60 on August 12, 2026. The advance was driven primarily by Chime's second-quarter 2026 earnings beat, a second consecutive GAAP profit, and raised full-year revenue guidance.

JHX shares rose roughly 27% over the 30 days through mid-August, from a July 13 closing level near $24.29 to about $30.86. The advance accelerated after James Hardie reported stronger-than-expected fiscal first-quarter 2027 results and raised its full-year sales and adjusted EBITDA guidance.

SMCI climbed roughly 36% in the last 30 days, rising from a closing price of $27.65 on July 14, 2026, to $37.61 on August 12, 2026. The rally was powered by a July 21 preliminary update disclosing more than $60 billion in fiscal-fourth-quarter new orders and a record backlog.

Selected price target: $60 per share, a psychological and technical level just above the August record high of $58.94. Strongest bullish factors: a proven acquisition-and-transformation model, Mizuho's raised $72.28 price target, and rapid revenue growth.

Unity Software shares rose about 40% over the last 30 days, from a July 14 close of $31.75 to $44.54 at the latest available quote. The main catalyst was Q2 2026 earnings on Aug. 6: revenue of $546 million beat consensus, while adjusted EBITDA reached $160 million.

Coeur Mining shares climbed roughly 17.5% over the trailing 30 days, from a closing price of $16.00 on July 14, 2026, to a latest available intraday price near $18.80. The advance was closely tied to a sharp rebound in silver, which recovered from about $56 per ounce in early August toward the $64–$66 range on safe-haven demand, a softer U.S. dollar, and lower Treasury yields.

Selected price target: $20 per share, roughly 54% above recent trading levels near $13. Strongest bullish factor: DURAVYU, the company's lead sustained-delivery eye treatment, is advancing through pivotal Phase 3 trials, with wet AMD data anticipated beginning in August 2026.

Selected stock price target: $40, which sits just above LEGN’s 52-week high of $38.35 and implies nearly double the recent price near $20.60. Strongest bullish factors: accelerating Carvykti sales, the first quarter of company-wide profitability, and promising early in vivo CAR-T data.

GFUZ is trading down -9.03% during Wednesday's regular session at $8.36, versus the prior close of $9.19. The decline follows Tuesday's +5.39% gain, putting shares in a sharp pullback amid continued post-SPAC volatility.

TOP Financial Group shares are down -8.55% during regular market hours on Aug. 12, slipping to $11.02 from the prior close of $12.05. The pullback follows a sharp post-consolidation rally after the company's 1-for-5 share consolidation took effect on Aug. 3.

WeRide shares are down -9.32% during regular U.S. trading, last near $5.74 after closing at $6.33 on Tuesday. The drop follows Q2 2026 results released before the open: revenue jumped +92% y/y to $34.15 million, but continued losses weighed on sentiment.

EYE shares fell -7.07% to $20.50 during regular trading Wednesday, erasing a roughly +2% premarket gain after its Q2 report. Q2 adjusted EPS of $0.25 beat the $0.18 consensus, but revenue of $498.8M missed estimates and adjusted comparable-store sales rose only +2.2%.

OBX traded down -15.25% to $27.88 during regular hours Wednesday, following a prior-session close at $32.90 (-6.00%). The decline extends a volatile post-debut stretch after the Aug 4 reverse merger with Galera and the $350 million private placement.